PhillyInc

Beijing Med-Pharm Corp., the Plymouth Meeting-based distributor of drugs in China (See archived stories here), says in an SEC filing that things may get tough if it cannot raise more capital soon. "If we are not able to raise additional capital through fund raising activities, we could be forced to curtail some of the currently anticipated expenditures in the above mentioned areas and our anticipated future growth will be adversely affected." The company employs a handful of people in Plymouth Meeting and scores in China, where it helps western drug companies distribute and market their products. The company told the SEC it is looking to raise additional funds in the next six months through public or private offerings, debt financing or from other sources. - Jonathan Berr